Access 1 Verified Employees Profiles for MorphochemUnlock Free Contacts Now
About
Morphochem has set out to introduce an innovative intravenous therapy for CDI, based on a novel antibacterial: MCB3681. We are truly excited about this opportunity to fill an unmet medical need and make a difference for CDI patients.